April 28, 20160Comments

What’s California’s Prescription For Rising Drug Costs?

By Pauline Bartolone, CALMatters April 21, 2016 SACRAMENTO — In a small room at a neighborhood clinic in Sacramento, a handful of hepatitis C patients wait to see their

by Michelle Sherman

April 25, 20160Comments

Medi-Cal AIDS Program Is Underfunded, Advocates Say

By Anna Gorman Photos by Heidi de Marco April 25, 2016 VAN NUYS, Calif. — Andy Martin’s body had rejected another HIV medication, and now his viral load

by Michelle Sherman

April 19, 20160Comments

Gonorrhea Rate Has Shot Up In California

By Barbara Feder Ostrov April 19, 2016 Rates of gonorrhea, a sexually transmitted disease, are rising sharply in California, especially among gay and bisexual men, according to new

by Michelle Sherman

April 12, 20160Comments

Covered California Imposes New Quality, Cost Conditions On Plans

By David Gorn April 8, 2016 Moving into a realm usually reserved for health care regulators, Covered California Thursday unveiled sweeping reforms to its contracts with insurers, seeking

by Michelle Sherman

April 7, 20160Comments

Descovy New NRTI backbone Approved By FDA

On April 4th the FDA approved Gilead Sciences new non nucleoside reverse transcriptase inhibitor backbone, DESCOVY. Descovy contains 200mg emtricitabine and 25mg tenofovir alafenamide (TAF) . Descovy contains less

by Michelle Sherman

March 31, 20160Comments

Anthem-Cigna Merger Proposal Takes a Grilling

By Ana B. Ibarra SAN FRANCISCO — State insurance commissioner Dave Jones continued to make his skepticism clear regarding Anthem Inc.’s proposed $54.2 billion acquisition of Cigna Corp. during a hearing

by Michelle Sherman

March 8, 20160Comments

PBM’s: The Wolf In Sheep’s Clothing

Prescription Benefit Managers (PBM’s) like Express Scripts, CVS Caremark and OptumRx are running rouge and although congress seems to be trying, their tactics and clandestine behavior are draining the healthcare

by Michelle Sherman

March 2, 20160Comments

Odefsey Approved By FDA

On March 1st the FDA approved a new HIV antiretroviral ODEFSEY. This medication contains the following drugs: emtricitabine 200mg, rilpivirine 25mg and tenofovir alafenamide 25mg. ODEFSEY is a fixed-dose combination

by Michelle Sherman

March 2, 20160Comments

CROI 2016- Fair Pricing Coalition

One of the panels at CROI was with members of the Fair Pricing Coalition who are continually fighting for fair pricing of HIV and Hepatitis C drugs, access to patient

by Michelle Sherman

February 24, 20160Comments

New Tenofovir Regimens Containing TAF (Tenofovir Alafenamide) What’s Different, What’s The Same

Tenofovir alafenamide (TAF) the new formulation and prodrug of the old tenofovir disoproxil fumarate known as was approved late last year in the single tablet regimen known as Genvoya. Genvoya contains

by Michelle Sherman

« Older Articles Newer Articles »